Simply replacing the connector in the IV system in patients with central lines could help reduce deadly bloodstream infections, researchers at Georgia Regents University have found.
A central line or central catheter is a tube placed in a patient’s arm or chest to help deliver fluids, blood, or medications through the large veins near the heart. A connector sits at the top of the catheter and serves as the entry point for the fluid pathway inside – any fluid that goes in or comes out of the body, goes through the connector.
Most connectors use positive or negative pressure – either pushing fluid out or drawing blood in – when catheters are disconnected for flushing and cleaning. Ironically, it’s during that process – designed to clean the catheter and ultimately reduce the chance of infection – that germs find their way into the bloodstream causing an often dangerous blood infection. Nearly 250,000 central line-associated bloodstream infections happen in hospitals each year, according to the Centers for Disease Control and Prevention. Mortality rates on CLABSIs range from 12 to 25 percent.
Treating them also costs health care systems billions of dollars each year.
“We know that both positive and negative needleless connectors have been associated with higher CLABSI rates, so we decided to see what role a zero fluid displacement connector would play in infection control,” said Dr. Cynthia C. Chernecky, a Professor of Nursing at GRU and corresponding author on the study published in the American Journal of Infection Control.
As their name indicates, zero fluid displacement connectors cause no reflux of fluids – out or in – during disconnection and connection.
Researchers analyzed data in six acute care settings in five states and found that the number of infections decreased by 60 percent when positive connectors were replaced with zero fluid displacement connectors and by 94 percent when negative connectors were replaced with the zero connectors for central line IV therapy.
“We estimate that replacing the connector devices saved about 13 lives in the acute care settings in this study,” Chernecky said. In addition to saving lives, more than $3 million was saved on health care costs. The average central line-associated bloodstream infection costs about $35,000 to treat.
Zero connectors cost about $1 a piece, Chernecky said. “This is a very cost-effective way to increase patient safety.”
The Latest Bing News on:
- Political leaders' attitudes toward COVID-19 risk are highly infectious in a polarized nation - just like climate change denialon October 13, 2020 at 7:08 am
Over 215,000 people have died from COVID-19 in the U.S., and the country faces a high risk of a surge in cases this fall. Wearing face masks and social distancing can help stop the virus’s spread.
- 25-Year-Old Man Becomes 1st in US to Contract Coronavirus Twice, With 2nd Infection ‘More Severe'on October 13, 2020 at 6:15 am
A 25-year-old man in the U.S. state of Nevada has contracted the coronavirus on two separate occasions, a study in the Lancet Infectious Diseases journal showed, with the patient becoming seriously ...
- Infections Back In China: Entire City Is Being Testedon October 13, 2020 at 6:02 am
The last time China reported locally transmitted cases was in August. News is from Denmark, Cuba and Mexico, as well.
- Gov. Andrew Cuomo's COVID book hits shelves Tuesday amid growing virus cases. What he writes.on October 13, 2020 at 5:57 am
Gov. Andrew Cuomo describes in his new book on the COVID-19 pandemic how he tried to balance getting more resources for New York last spring with his disdain for the way the Trump administration was ...
- Qingdao COVID-19 cases may be due to cross-infection in hospitalon October 13, 2020 at 4:26 am
VCG With no clear sign pointing to the source of a recent flare-up of COVID-19 in Qingdao, East China's Shandong Province, health experts speculated that there might have been a cross-infection within ...
- Southampton Hospital's Director Of Infection Prevention Earns Re-certification In Infection Controlon October 12, 2020 at 10:35 am
"Patient safety at Southampton Hospital is of critical importance and Deborah Maile is an important asset to our team," noted Robert S. Chaloner, Southampton Hospital President & CEO. "In addition to ...
- Sterilization Services Market: Rise in Prevalence of Hospital-acquired Infections to Drive Global Marketon October 12, 2020 at 1:03 am
Increase in the number of surgeries, growth of the pharmaceutical & biotechnology industry, and rise in number of hospital-acquired/associated infections are the major factors anticipated to drive the ...
- Chris Christie released from hospital following coronavirus infectionon October 11, 2020 at 7:02 am
Former New Jersey Gov. Chris Christie has been released from a hospital after becoming infected with the coronavirus.
- Tehran scrambles for hospital beds as Iran reports record new coronavirus caseson October 8, 2020 at 5:42 am
DUBAI, Oct 8 (Reuters) - Tehran ambulances carrying COVID-19 patients go from hospital to hospital in search of available beds, a physician said on Thursday as the country recorded a daily high of ...
- Q&A: Infection Preventionists at Children’s Hospital Were Ready When COVID Struckon October 6, 2020 at 5:00 pm
Sarah Smathers, MPH, CIC, FAPIC, adjunct professor and co-director of the Certificate in Infectious Disease Prevention and Control at the Dornsife School of Public Health and system director of ...
The Latest Google Headlines on:
The Latest Bing News on:
- Blood donation scheduled in Foreston October 13, 2020 at 6:00 am
There will be a blood donation opportunity from 2 to 7 p.m. Wednesday, Oct. 21 at McVitty Memorial VFW Post 1182, 204 W. Lima St., Forest.
- Cerus bags $11M FDA contract to treat whole blood; shares +5%on October 13, 2020 at 5:54 am
Cerus (NASDAQ:CERS) ha been awarded a five-year contract valued at $11.1M with the FDA for the development of next-generation compounds to optimize pathogen reduction (PR) treatment of whole blood to ...
- Cerus Corporation Announces Five-Year FDA Contract for the Development of Next Generation Pathogen Reduction Technology to Treat Whole Bloodon October 13, 2020 at 5:45 am
Cerus Corporation (Nasdaq:CERS) announced today it was awarded a five-year contract with the U.S. Food and Drug Administration (FDA) for the development of next-generation compounds to optimize ...
- Why blood type O might lower risk for SARS-CoV-2 infectionon October 12, 2020 at 8:18 pm
O blood groups may have highest contact with the SARS-CoV-2 virus via the formation of in intermediate structure, resulting in possibly higher infection rates and more severe symptoms.
- Dynamic map reveals how cells fight microbes and preserve memory for future infectionson October 12, 2020 at 5:15 pm
Researchers have charted the activity of tens of thousands of genes in mouse immune cells over the course of an infection.
- Novel map reveals how immune cells fight and remember infectionson October 12, 2020 at 4:27 pm
Researchers have created the first full dynamic map of how cells learn to fight microbes and then preserve a memory of this for future infections, by mapping the activity of tens of thousands of genes ...
- Mobile Blood Donations Set For This Week In Coachella Valleyon October 12, 2020 at 2:36 pm
LifeStream Blood Bank, which says it is experiencing a "critical" shortage of donated blood, will hold several mobile blood drives this week in the Coachella Valley, where donors also will be screened ...
- Abbott Receives FDA Emergency Use Authorization for its COVID-19 IgM Antibody Blood Teston October 12, 2020 at 11:50 am
Abbott (NYSE: ABT) announced today that the U.S. Food and Drug Administration (FDA) issued Emergency Use Authorization (EUA) for the company's AdviseDx SARS-CoV-2 IgM (Immunoglobulin M) lab-based ...
- Abbott's new COVID-19 test detects more recent infectionson October 12, 2020 at 8:21 am
Abbott Laboratories is launching a new blood test that aims to help doctors better treat patients recovering from COVID-19 by determining more recent infections. The North Chicago medical device maker ...
- Global Blood Transfusion Diagnostics Market Outlook to 2027 - Impact of COVID-19on October 12, 2020 at 2:40 am
The "Blood Transfusion Diagnostics - Global Market Outlook (2019-2027)" report has been added to ResearchAndMarkets.com's offering. According to the report, the Global blood Transfusion Diagnostics ...